IRADIMED CORPORATION Total Liabilities and Equity
IRADIMED CORPORATION (IRMD) had Total Liabilities and Equity of $114.97 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-07-31
- 2026-06-30: Liabilities and Equity $114.97M.
- 2026-03-31: Liabilities and Equity $114.39M.
- 2025-12-31: Liabilities and Equity $108.78M.
- 2025-09-30: Liabilities and Equity $114.72M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $114.97M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $114.39M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $108.78M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $114.72M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $106.45M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $101.73M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $98.33M 10-K · filed 2026-03-06 | $98.33M 10-K · filed 2025-03-06 |
| 2024-09-30 | $94.25M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $89.95M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $88.01M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $92.16M 10-K/A · filed 2025-09-03 | |
| 2023-09-30 | $87.41M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $81.43M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $75.62M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $85.51M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $79.54M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $75.72M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $72.39M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $82.88M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $78.40M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $75.58M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $72.19M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $71.07M 10-K · filed 2022-03-04 | |
| 2020-09-30 | $70.43M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $68.82M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $68.37M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $66.73M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $62.57M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $56.84M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $54.41M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $48.44M 10-K · filed 2020-03-06 | |
| 2018-09-30 | $46.81M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $42.83M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $40.26M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $39.01M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $37.92M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $36.84M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $37.42M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $37.19M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $35.49M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $32.35M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $33.45M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $35.24M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $31.05M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $28.76M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $26.01M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $23.31M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $22.41M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $9.94M 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $6.99M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |